SurGenTec Receives US Patent for GRAFTGUN
SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® device. May 25, 2017
Anika Enrolls First Patient in Supplemental Phase III CINGAL Trial
Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL® viscosupplement for the treatment of knee OA symptoms. May 25, 2017
LITHOMED to Distribute SANUWAVE Orthopaedic Products in Taiwan
SANUWAVE Health appointed LITHOMED to distribute the orthoPACE® shockwave therapy device in Taiwan. May 25, 2017
NovaBone Adds New Biologically-active Bone Graft Substitutes
NovaBone Products launched NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically-active bone graft substitutes. May 24, 2017
First Surgery Completed with Gramercy Extremity Orthopedic Systems
Gramercy Extremity Orthopedics announced completion of the first surgery using its GEO™ Bone Screw and GEO CART™ systems. May 24, 2017
United Orthopedic Enrolls First Patient in U2 Knee Study
United Orthopedic enrolled its first patient in a study of the U2 Knee™, evaluating the system’s use in primary total knee arthroplasty. May 23, 2017
Zimmer Biomet Issues Voluntary Field Action on Rosa Platforms
Zimmer Biomet issued a voluntary field safety corrective action for certain ROSA Brain, Spine and One surgical robotic devices due to internal identification of an issue that may prevent the robot arm from reaching a desired position. The issue has not been identified in the field. May 23, 2017
NuVasive Initiatives Support Pediatric Spinal Deformity Research and Treatment
NuVasive is increasing investment in support of adult/pediatric spinal deformity research and education, and expects to launch the RELINE® Small Stature posterior fixation system this summer. May 23, 2017
CINGAL Phase III Data Demonstrates Efficacy and Safety to Treat Knee OA Pain
Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection vs. hyaluronic acid alone, and superior relief at 26 weeks vs. saline. May 23, 2017
Integra LifeSciences to Distribute aap Implantate’s LOQTEQ Distal Radius System
Integra LifeSciences signed an agreement with aap Implantate to distribute the LOQTEQ® Distal Radius System in the U.S. May 23, 2017
